Medicare Enrolled

Dr. Hasan Abualula, MD

Rheumatology · Summerfield, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
10250 SE 167TH PLACE RD, Summerfield, FL 34491
3523079925
Registered in NPPES since 2009
NPI: 1508008228 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Abualula from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Abualula? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Abualula

Dr. Hasan Abualula is a rheumatology specialist in Summerfield, FL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Abualula performed 100,009 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Abualula received a total of $14,910 from 39 pharmaceutical and/or device companies across 803 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Abualula is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years of NPI registration ▲ Top 25% volume in FL $14,910 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
100,009
Medicare services
Top 25% in FL for rheumatology
Not available
Unique patients (not deduplicated)
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia)
An injection of certolizumab pegol administered under the direct supervision of a physician.
83,900 $4 $15
Abatacept infusion (Orencia)
An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered.
8,875 $34 $85
Denosumab injection (Prolia/Xgeva) 3,960 $18 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
565 $90 $195
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
438 $8 $10
Non-hormonal chemotherapy injection
This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue.
419 $55 $110
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
347 $10 $20
Sed rate test (inflammation marker)
This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body.
342 $3 $5
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
335 $8 $15
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
167 $1 $5
Intravenous infusion, 1 hour or less
Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less.
152 $48 $110
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
127 $11 $26
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
118 $120 $255
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
68 $29 $45
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
29 $16 $30
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
28 $60 $110
Uric acid level test
A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines.
27 $4 $10
Free thyroxine (T4) test
A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream.
26 $9 $15
Lipid panel (cholesterol and triglycerides)
A blood test that measures cholesterol and triglyceride levels.
23 $13 $25
LDL cholesterol level test
A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol.
23 $10 $20
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
14 $15 $25
Hemoglobin analysis by chromatography
A laboratory test that uses chromatography to separate and measure different types of hemoglobin in the blood.
14 $18 $30
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
12 $70 $140
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
9.2% high complexity
88.4% medium
2.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,910
Total received (2018-2024)
Avg $2,130/year across 7 years
Top 33% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
803
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,640
2023
$2,841
2022
$3,124
2021
$2,434
2020
$1,558
2019
$1,339
2018
$974

Payments by company (2024)

Amgen Inc.
$630
Janssen Biotech, Inc.
$399
ABBVIE INC.
$394
PFIZER INC.
$223
Lilly USA, LLC
$210
Novartis Pharmaceuticals Corporation
$210
UCB, Inc.
$168
GlaxoSmithKline, LLC.
$134
Boehringer Ingelheim Pharmaceuticals, Inc.
$76
ANI Pharmaceuticals, Inc.
$51
Organon Llc
$44
Boston Scientific Corporation
$35
AstraZeneca Pharmaceuticals LP
$26
Merck Sharp & Dohme LLC
$21
Ethicon US, LLC
$19
Top 3 companies account for 53.9% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$3,203
UCB, Inc.
$1,446
Janssen Biotech, Inc.
$1,437
AbbVie Inc.
$1,322
PFIZER INC.
$1,240
ABBVIE INC.
$1,071
Horizon Therapeutics plc
$937
Novartis Pharmaceuticals Corporation
$843
Lilly USA, LLC
$714
GENZYME CORPORATION
$371
AbbVie, Inc.
$327
GlaxoSmithKline, LLC.
$266
E.R. Squibb & Sons, L.L.C.
$262
Genentech USA, Inc.
$233
AstraZeneca Pharmaceuticals LP
$196
Boehringer Ingelheim Pharmaceuticals, Inc.
$158
Horizon Pharma plc
$141
Janssen Pharmaceuticals, Inc
$87
Fresenius Kabi USA, LLC
$67
Mallinckrodt Enterprises LLC
$65
Aurinia Pharma U.S., Inc.
$57
ANI Pharmaceuticals, Inc.
$51
Boston Scientific Corporation
$48
Organon Llc
$44
Sobi, Inc
$38
MITSUBISHI TANABE PHARMA AMERICA, INC.
$38
Paratek Pharmaceuticals, Inc.
$37
Radius Health, Inc.
$28
Sunovion Pharmaceuticals Inc.
$24
Organon LLC
$23
Merck Sharp & Dohme LLC
$21
Ethicon US, LLC
$19
Mallinckrodt LLC
$18
Avion Pharmaceuticals
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$14
SOBI, INC
$13
Bioventus LLC
$11
Amarin Pharma Inc.
$11
Novo Nordisk Inc
$11
Top 3 companies account for 40.8% of all-time payments
Associated products mentioned in payments ›
ACTHAR · APTIOM · Actemra · Aimovig · BENLYSTA · Balcoltra · Bimzelx · COSENTYX · CYLTEZO · Cimzia · DIFICID · Durolane · EVENITY · Enbrel · HADLIMA · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · NUZYRA · OFEV · ORENCIA · Ocrevus · Otezla · PURIFIED CORTROPHIN GEL · RADICAVA · RAYOS · RENFLEXIS · RINVOQ · Rinvoq · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · SPECTRA WAVEWRITER · STRATAFIX · TALTZ · TAVNEOS · TREMFYA · Tresiba · Vascepa · WATCHMAN FLX · XELJANZ · XIFAXANIBSD
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Summerfield?
Compare rheumatologists in the Summerfield area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
7
County median income
$58,535
Nearest hospital to ZIP centroid (approximate)
VILLAGES REGIONAL HOSPITAL, THE
10.2 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Abualula is a mixed practice specialist, with above-average Medicare volume (top 25% in FL), with 17 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Abualula experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Abualula performed 83,900 certolizumab injection (cimzia) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Abualula receive payments from pharmaceutical companies?
Yes. Dr. Abualula received a total of $14,910 from 39 companies across 803 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Abualula's costs compare to other rheumatologists in Summerfield?
Dr. Abualula's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Abualula) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →